Global Digital Dose Inhaler Market Is Expected To Reach At A CAGR Of 18.23% Between 2024 And 2032

Digital Dose Inhaler Market Analysis

According to the report, the global digital dose inhaler market size was valued at approximately USD 15.37 billion in 2023 and is projected to reach around USD 69.38 billion by the end of 2032, expanding at a CAGR of approximately 18.23% from 2024 to 2032.

A medical device that delivers medication into the body through the lungs is called an inhaler. These are also referred to as pump, puffer, or allergy sprays. Inhalers have great significance in chronic respiratory diseases. These inhalers are most commonly used for medication delivery and treatment of various respiratory diseases like asthma, COPD (chronic obstructive pulmonary disease), and other respiratory diseases. Inhalers decrease deposition of medication in the mouth or throat and also reduce the need for exact synchronization with actuation of the device. Digital inhalers are equipped with built-in sensors that help in tracking usage of inhalers, dose management and dose compliance. 

The global digital dose inhaler market growth is fueled by the growing prevalence of chronic respiratory diseases like COPD, asthma, and associated decrease in patients' quality of life. Growing elderly population across the globe, increasing R&D investment for device miniaturization and technological enhancement of devices, growing preference and adoption of digital devices, mounting need to achieve medication compliance and better patient care and dose tracking are additional factors that propel the market growth.

However, the high cost of devices may hamper the market growth in the coming years. Incorporation of artificial intelligence (AI) for digital dose compliance and dose tracking is projected to bring new growth avenues for major market players working in the digital dose inhaler.

Digital Dose Inhaler Market: Report Scope

The global digital dose inhaler market is segmented based on application, product, and region. Metered dose inhalers (MDIs) and dry powder inhalers (DPIs) are product type segments of the digital dose inhaler market. Among product segments, metered dose inhalers (MDIs) held almost two-thirds revenue share in 2023. This large share is attributed to noteworthy innovations like automatic pharmacokinetic/pharmacodynamics (PK/PD) modeling, controlled release of formulations and electronic monitoring systems with patient feedback. Fastest growth is expected for the dry powder inhalers (DPIs) product type segment over the forecast period. 

Based on application, the market is segmented into chronic obstructive pulmonary disease (COPD), asthma, and other applications. The largest share was held by the asthma application segment in 2023. On the other hand, the chronic obstructive pulmonary disease (COPD) application segment is projected to witness rapid growth in the coming years. Increasing asthma prevalence worldwide has contributed to this largest revenue share. 

At the regional level, North America held dominating market share for the global digital dose inhaler market in 2023. Various factors such as increasing preference and adoption of digital devices, growing prevalence of chronic respiratory disorders, an aging population and the presence of major market players in this region help drive the market in this region. Europe was the second-largest regional market. Presence of developed infrastructure, growing prevalence of respiratory disorders and increasing awareness are important factors that support market growth in this region.

Latin America is projected to witness modest growth during the forecast period. Asia Pacific region will show the fastest growth for the digital dose inhaler market over the forecast period. A growing elderly population with high susceptibility to respiratory disorders, increasing prevalence of COPD, asthma, and increasing healthcare spending are factors stimulating market growth in Asia Pacific. Middle East and Africa will register noticeable growth in the future.

Browse the full “Digital Dose Inhaler Market By Product (Dry Powder Inhalers (DPIs) and Metered Dose Inhalers (MDIs)), By Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Other Applications), and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032” Report at https://www.zionmarketresearch.com/report/digital-dose-inhaler-market

Major players included in the report are Teva Pharmaceuticals Industries Ltd., Philips Respironics, Novartis AG, AstraZeneca Plc, Opko Health, Inc., Propeller Health, GlaxoSmithKline plc., Glenmark Pharmaceuticals Ltd., Cipla, Inc., AptarGroup, Inc., and others.

The report segment of the global digital dose inhaler market is as follows:

By Product

• Dry Powder Inhalers (DPIs)
• Metered Dose Inhalers (MDIs)

By Application

• Chronic Obstructive Pulmonary Disease (COPD)
• Asthma
• Other Applications

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us-after all-if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
US OFFICE NO: +1 (302) 444-0166
USA/Canada Toll-Free No: 1-855-465-4651
APAC: +91 7768 006 007, +91 7768 006 008
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com